Propionate and Alzheimer's Disease
- PMID: 33505301
- PMCID: PMC7831739
- DOI: 10.3389/fnagi.2020.580001
Propionate and Alzheimer's Disease
Abstract
Propionate, a short-chain fatty acid, serves important roles in the human body. However, our review of the current literature suggests that under certain conditions, excess levels of propionate may play a role in Alzheimer's disease (AD). The cause of the excessive levels of propionate may be related to the Bacteroidetes phylum, which are the primary producers of propionate in the human gut. Studies have shown that the relative abundance of the Bacteroidetes phylum is significantly increased in older adults. Other studies have shown that levels of the Bacteroidetes phylum are increased in persons with AD. Studies on the diet, medication use, and propionate metabolism offer additional potential causes. There are many different mechanisms by which excess levels of propionate may lead to AD, such as hyperammonemia. These mechanisms offer potential points for intervention.
Keywords: Alzheimer’s disease; gut microbiome; propionate; short chain fatty acids; valproate.
Copyright © 2021 Killingsworth, Sawmiller and Shytle.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment.EBioMedicine. 2019 Sep;47:529-542. doi: 10.1016/j.ebiom.2019.08.032. Epub 2019 Aug 30. EBioMedicine. 2019. PMID: 31477562 Free PMC article.
-
Cultivable butyrate-producing bacteria of elderly Japanese diagnosed with Alzheimer's disease.J Microbiol. 2018 Oct;56(10):760-771. doi: 10.1007/s12275-018-8297-7. Epub 2018 Aug 22. J Microbiol. 2018. PMID: 30136260
-
The Effects of Gum Acacia on the Composition of the Gut Microbiome and Plasma Levels of Short-Chain Fatty Acids in a Rat Model of Chronic Kidney Disease.Front Pharmacol. 2020 Dec 22;11:569402. doi: 10.3389/fphar.2020.569402. eCollection 2020. Front Pharmacol. 2020. PMID: 33628167 Free PMC article.
-
The Microbiota-Gut-Brain Axis in Alzheimer's Disease: A Review of Taxonomic Alterations and Potential Avenues for Interventions.Arch Clin Neuropsychol. 2022 Feb 22;37(3):595-607. doi: 10.1093/arclin/acac008. Arch Clin Neuropsychol. 2022. PMID: 35202456 Free PMC article. Review.
-
Alzheimer's Disease and Diabetes: Role of Diet, Microbiota and Inflammation in Preclinical Models.Biomolecules. 2021 Feb 10;11(2):262. doi: 10.3390/biom11020262. Biomolecules. 2021. PMID: 33578998 Free PMC article. Review.
Cited by
-
Propionic and valproic acids have an impact on bacteria viability, proton flux and ATPase activity.J Bioenerg Biomembr. 2023 Oct;55(5):397-408. doi: 10.1007/s10863-023-09983-6. Epub 2023 Sep 13. J Bioenerg Biomembr. 2023. PMID: 37700074
-
Gut dysbiosis impacts the immune system and promotes prostate cancer.Immunol Lett. 2024 Aug;268:106883. doi: 10.1016/j.imlet.2024.106883. Epub 2024 Jun 8. Immunol Lett. 2024. PMID: 38852888 Free PMC article. Review.
-
Microbiota-derived short chain fatty acids in pediatric health and diseases: from gut development to neuroprotection.Front Microbiol. 2024 Oct 8;15:1456793. doi: 10.3389/fmicb.2024.1456793. eCollection 2024. Front Microbiol. 2024. PMID: 39439941 Free PMC article. Review.
-
Identification of biomarkers related to propionate metabolism in schizophrenia.Front Psychiatry. 2025 Apr 2;16:1504699. doi: 10.3389/fpsyt.2025.1504699. eCollection 2025. Front Psychiatry. 2025. PMID: 40242178 Free PMC article.
-
Small Intestinal Permeability and Metabolomic Profiles in Feces and Plasma Associate With Clinical Response in Patients With Active Psoriatic Arthritis Participating in a Fecal Microbiota Transplantation Trial: Exploratory Findings From the FLORA Trial.ACR Open Rheumatol. 2023 Nov;5(11):583-593. doi: 10.1002/acr2.11604. Epub 2023 Sep 22. ACR Open Rheumatol. 2023. PMID: 37736702 Free PMC article.
References
-
- Aimetti M., Cacciatore S., Graziano A., Tenori L. (2011). Metabonomic analysis of saliva reveals generalized chronic periodontitis signature. Metabolomics 8, 465–474. 10.1007/s11306-011-0331-2 - DOI
-
- Ali M. R. A.-A., Abo-Youssef A. M. H., Messiha B. A. S., Khattab M. M. (2016). Tempol and perindopril protect against lipopolysaccharide-induced cognition impairment and amyloidogenesis by modulating brain-derived neurotropic factor, neuroinflammation and oxido-nitrosative stress. Naunyn Schmiedebergs Arch. Pharmacol. 389, 637–656. 10.1007/s00210-016-1234-6 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical